Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | PYGB | P11216 | 2/20 | 0.46 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18095805 | 1.00 | ALDH1A1 (0.53) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL18095809 | 1.00 | ALDH1A1 (0.53) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL17771655 | 0.90 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL12936319 | 0.90 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL18095829 | 0.86 | ALDH1A1 (0.50) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL16393013 | 0.85 | ALDH1A1 (0.55) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL22431361 | 0.85 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL20842452 | 0.85 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL18735615 | 0.85 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 | |
| SCHEMBL18573708 | 0.85 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1PYGBCD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10435383-B2 | C-glycoside derivatives | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2019-10-08 | — | — | US | disclosed |
| US-10435383-B2 | C-glycoside derivatives | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2019-10-08 | — | — | US | disclosed |
| US-20180118703-A1 | C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20180118703-A1 | C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20180118703-A1 | C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| WO-2016151989-A1 | C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2016-09-29 | — | — | WO | disclosed |
| WO-2016151989-A1 | C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2016-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435383-B2 | C-glycoside derivatives | UGCG, FUT6, FUT5 | ALDH1A1 1520/4885THRB 4329/4885MAPK1 4004/4885 |
| US-20180118703-A1 | C-GLYCOSIDE DERIVATIVES | UGCG, FUT6, FUT5 | ALDH1A1 1520/4885THRB 4329/4885MAPK1 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.